Wellysis
PrivateLast Round
Growth Equity
Jan 3, 2026
Total Funding Raised
$24.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Wellysis operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Growth Equity round in January 2026.
Wellysis is a digital healthcare company that develops a smart wearable device and an AI-assisted platform for ECG monitoring and analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellysis Comparables
Compare Wellysis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ATsens | 93% | |
| Huinno | 91% | |
| iRhythm Technologies | 83% |
For institutional investors. Book with your work email.
Wellysis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 3, 2026 | ||||
| Series B | May 30, 2022 | ||||
| Series A | Dec 10, 2020 | ||||
| Seed | Sep 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wellysis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Growth Equity |
| Hanyang University Technology Holdings | Seed |
| Samsung Securities Co., Ltd. | Growth Equity |
| Ulmus Investment | Series A |
| Almas Global Opportunity Fund | Seed |
| Kyobo Securities Co., Ltd. | Growth Equity |
| NCORE Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jun 19, 2026
Monthly visitors increased 61% MoM, reaching 5.3K.
For institutional investors. Book with your work email.
Wellysis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wellysis's valuation, stock price, and market status.
Is Wellysis a public or private company?
Wellysis is a private company.
What is the current stock price of Wellysis?
Wellysis is a private company, so its shares have no public market price. Caplight tracks Wellysis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wellysis worth (valuation)?
Valuation information for Wellysis is not publicly available.
Can I buy Wellysis stock?
Wellysis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wellysis's last funding round?
Wellysis's most recent funding round was Growth Equity on January 3, 2026.
Who are the main investors in Wellysis?
Key investors in Wellysis include Korea Investment Partners, Ulmus Investment, Kyobo Securities Co., Ltd., NCORE Ventures, Kolon Investment.
Will Wellysis IPO soon?
No public IPO plans have been announced for Wellysis.
How can I track Wellysis secondary market activity?
Caplight tracks bids, offers, and trades in Wellysis's shares on secondary markets.